Home › Funds › BSN Capital Partners Ltd › APH
BSN Capital Partners Ltd position in APH
AMPHENOL CORP · Technology
BSN Capital Partners Ltd reported holding 220,000 shares of APH (AMPHENOL CORP) in its Q2 2026 13F filing — a position valued at US$35.8M, representing 1.62% of its reported portfolio and ranking #16 among its reported holdings. BSN Capital Partners Ltd has disclosed APH holdings in 2 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BSN Capital Partners Ltd's APH position evolved
BSN Capital Partners Ltd first disclosed a stake in APH in Q3 2024 at 119,458 shares (US$8.3M). The position peaked in Q2 2026 at 220,000 shares, worth US$35.8M. Across 2 filings, BSN Capital Partners Ltd held the position steady without any share-count change. The most recent filing (Q2 2026) shows 220,000 shares valued at US$35.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 119.46K | $8.33M | New |
| Q2 2026 | 220.00K | $35.81M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APH and 13F data
APH (AMPHENOL CORP) is a Technology company. 51 other funds we track also report a position in APH — the largest reported positions include BlackRock Inc (US$17.85B), Fidelity Management & Research (FMR) (US$12.44B), Capital International Investors (US$7.59B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APH
- BlackRock Inc 101.25M sh · $17.85B · Q2 2026
- Fidelity Management & Research (FMR) 70.57M sh · $12.44B · Q2 2026
- Capital International Investors 43.04M sh · $7.59B · Q2 2026
- JPMorgan Chase & Co 39.20M sh · $6.52B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 35.69M sh · $6.29B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 32.01M sh · $5.64B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Wellington Management Group 16.58M sh · $2.92B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 16.58M sh · $2.92B · Q2 2026
- Nuveen, LLC 15.07M sh · $2.66B · Q2 2026
- BNY Mellon 14.57M sh · $2.57B · Q2 2026
More on BSN Capital Partners Ltd
FAQ
How long has BSN Capital Partners Ltd held APH?
BSN Capital Partners Ltd has disclosed APH holdings in 2 of the last 8 reported quarters, going back to Q3 2024.
What is BSN Capital Partners Ltd's current position in APH?
As of Q2 2026, BSN Capital Partners Ltd holds 220.00K shares of APH (AMPHENOL CORP), valued at $35.81M, representing 1.62% of its reported portfolio and ranking #16.
Has BSN Capital Partners Ltd been buying or selling APH?
In the latest 13F filing (Q2 2026), BSN Capital Partners Ltd newly opened its position in APH. The position peaked in Q2 2026 at 220.00K shares.
Which other funds hold APH?
Other major institutional holders of APH include BlackRock Inc, Fidelity Management & Research (FMR), Capital International Investors, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.